Our Products

Imatinib Tablets IP 100 mg is a medication used to treat certain types of cancer, most commonly chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other malignancies, including some cases of systemic mastocytosis. Imatinib is a tyrosine kinase inhibitor that works by blocking the abnormal signals in cancer cells caused by specific proteins like BCR-ABL in CML or c-KIT in GISTs. By inhibiting these signals, Imatinib helps prevent the growth and spread of cancer cells.

The 100 mg dose is typically taken once daily, as directed by a healthcare provider, and the dosage may be adjusted depending on the condition being treated. Common side effects include nausea, fatigue, fluid retention, muscle cramps, and headaches. Regular monitoring, including blood tests, is important during treatment to ensure the drug is working effectively and to manage potential side effects.